Follow the 삼진제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼진제약 has recorded 89 public disclosures. The latest transaction was reported on 25 August 2026 (Purchase). Among the most active insiders: 전상진. Every trade is accessible without an account.
76
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Samjin Pharmaceutical is a South Korean pharmaceutical company focused on the research, development, and manufacturing of medications. It is listed on the Korea Exchange, XKRX.